Advertisement

Topics

CENTOGENE Company Profile

13:32 EDT 20th October 2018 | BioPortfolio

CENTOGENE unlocks the power of genetic insights to improve the quality of life of patients with rare genetic diseases. We achieve this through knowledge created by our worldwide diagnostic testing services incorporating global diversity, the world’s leading proprietary human genetic interpretation database, CentoMD® and solutions for pharmaceutical companies developing life-changing orphan drugs.


News Articles [40 Associated News Articles listed on BioPortfolio]

CENTOGENE to Open First U.S. Laboratory in Cambridge, MA Focused on Rare Genetic Diseases ...

Centogene:Ruxandra Lenz, +49 30 213 000 323Director CommunicationsRuxandra.Lenz@centogene.comorMedia Contact:MacDougall Biomedical CommunicationsLauren Arnold, +1 781-235-3060larn...

Evotec: "Potenzial, ein neues Kapitel aufzuschlagen"

Wie Evotec zum Wochenstart bekannt gab, ist man mit Centogene eine globale strategische Vereinbarung für gemeinsame Wirkstoffforschungsprojekte eingegangen. Centogene ist weltweit führen bei der ge....

Centogene and Aldeyra Therapeutics Partner to Advance Novel Therapeutics for Patients with Sjögren-Larsson Syndrome

ROSTOCK, Germany–(BUSINESS WIRE)–CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, today announced that it has ente...

Evotec und Centogene gehen globale strategische Partnerschaft ein

Die Evotec AG (ISIN: DE0005664809) gab heute bekannt, dass CENTOGENE AG, ein Unternehmen, das bei der genetischen Entschlüsselung seltener Krankheiten für Patienten, Kliniker und pharmazeutische Pa....

Evotec and Centogene sign partnership on drug discovery projects in rare genetic diseases

Evotec AG announced that CENTOGENE AG and Evotec entered into a global strategic collaboration agreement for joint drug discovery projects, developing compounds to treat rare genetic diseases. Evotec ...

Evotec AG (EVT-DE): Evotec and Centogene join -2-

DJ Evotec AG (EVT-DE): Evotec and Centogene join forces in rare diseases Dow Jones received a payment from EQS/DGAP to publish this press release. goetzpartners securities Limited Evotec AG (EVT-D...

CENTOGENE and Evotec Sign Global Strategic Partnership on Drug Discovery Projects in Rare ...

Joint Drug Discovery Projects Combine CENTOGENE’s Patient Access and Biomarker Expertise with Evotec’s Leading iPSC Platform Read more...

Centogene and Evotec Sign Global Strategic Partnership on Drug Discovery Projects

NewsThe collaboration brings together Evotec’s induced pluripotent stem cell platform and broad drug discovery capabilities with Centogene's medical and genetic insights.

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

CENTOGENE

CENTOGENE unlocks the power of genetic insights to improve the quality of life of patients with rare genetic diseases. We achieve this through knowledge created by our worldwide d...

More Information about "CENTOGENE" on BioPortfolio

We have published hundreds of CENTOGENE news stories on BioPortfolio along with dozens of CENTOGENE Clinical Trials and PubMed Articles about CENTOGENE for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CENTOGENE Companies in our database. You can also find out about relevant CENTOGENE Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record